Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Dahan

Showing results (241-250 of 249) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 249 results.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 26, 2023
Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy lossShorooq Banjar, Einav Kadour, Rabea Khoudja, et al.
Reproductive Biology and Endocrinology : RB&E|October 9, 2024
Patients with low prognosis in ART: a Delphi consensus to identify potential clinical implications and measure the impact of POSEIDON criteriaCarlo Alviggi, Peter Humaidan, Robert Fischer, et al.
Turkish Journal of Obstetrics and Gynecology|September 4, 2024
True empty follicle syndrome is a subtype of oocyte maturation abnormalitiesŞafak Hatırnaz, Ebru Hatırnaz, Justin Tan, et al.
Scientific Reports|February 16, 2024
Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomesEinav Kadour Peero, Shorooq Banjar, Rabea Khoudja, et al.
Reproduction (Cambridge, England)|November 2, 2022
Immunomodulation for unexplained recurrent implantation failure: where are we now?Geneviève Genest, Shorooq Banjar, Walaa Almasri, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 31, 2025
Outcomes of Ultimpro Testing Implementation for Patients With Unexplained Recurrent Implantation Failure: A Single-Center Retrospective Cohort StudyGenevieve Genest, Alyssa Hochberg, Martine Boivin, et al.
Journal of Assisted Reproduction and Genetics|March 18, 2023
The HERA (Hyper-response Risk Assessment) Delphi consensus definition of hyper-responders for in-vitro fertilizationIdo Feferkorn, B Ata, S C Esteves, et al.
Journal of Assisted Reproduction and Genetics|September 15, 2023
The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilizationI Feferkorn, S Santos-Ribeiro, F M Ubaldi, et al.
Reproductive Biology and Endocrinology : RB&E|May 15, 2020
COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical managementCarlo Alviggi, Sandro C Esteves, Raoul Orvieto, et al.
Pageof 25

Showing results (241-250 of 249) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 249 results.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 26, 2023
Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy lossShorooq Banjar, Einav Kadour, Rabea Khoudja, et al.
Reproductive Biology and Endocrinology : RB&E|October 9, 2024
Patients with low prognosis in ART: a Delphi consensus to identify potential clinical implications and measure the impact of POSEIDON criteriaCarlo Alviggi, Peter Humaidan, Robert Fischer, et al.
Turkish Journal of Obstetrics and Gynecology|September 4, 2024
True empty follicle syndrome is a subtype of oocyte maturation abnormalitiesŞafak Hatırnaz, Ebru Hatırnaz, Justin Tan, et al.
Scientific Reports|February 16, 2024
Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomesEinav Kadour Peero, Shorooq Banjar, Rabea Khoudja, et al.
Reproduction (Cambridge, England)|November 2, 2022
Immunomodulation for unexplained recurrent implantation failure: where are we now?Geneviève Genest, Shorooq Banjar, Walaa Almasri, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 31, 2025
Outcomes of Ultimpro Testing Implementation for Patients With Unexplained Recurrent Implantation Failure: A Single-Center Retrospective Cohort StudyGenevieve Genest, Alyssa Hochberg, Martine Boivin, et al.
Journal of Assisted Reproduction and Genetics|March 18, 2023
The HERA (Hyper-response Risk Assessment) Delphi consensus definition of hyper-responders for in-vitro fertilizationIdo Feferkorn, B Ata, S C Esteves, et al.
Journal of Assisted Reproduction and Genetics|September 15, 2023
The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilizationI Feferkorn, S Santos-Ribeiro, F M Ubaldi, et al.
Reproductive Biology and Endocrinology : RB&E|May 15, 2020
COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical managementCarlo Alviggi, Sandro C Esteves, Raoul Orvieto, et al.
Pageof 25